Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue-Reference-Cited by-同舟云学术

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

Published:2015-09-25 Issue:5 Volume:78 Page:787-800
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Marquié Marta¹²³,Normandin Marc D.⁴,Vanderburg Charles R.¹²⁵,Costantino Isabel M.¹²,Bien Elizabeth A.¹²⁵,Rycyna Lisa G.¹²⁵,Klunk William E.⁶,Mathis Chester A.⁷,Ikonomovic Milos D.⁸⁹,Debnath Manik L.⁶,Vasdev Neil⁴,Dickerson Bradford C.²,Gomperts Stephen N.¹²,Growdon John H.²,Johnson Keith A.²,Frosch Matthew P.¹²¹⁰,Hyman Bradley T.¹²⁵,Gómez-Isla Teresa¹²

Affiliation:

1. MassGeneral Institute for Neurodegenerative Disease; Charlestown MA

2. Department of Neurology; Massachusetts General Hospital; Boston MA

3. Autonomous University of Barcelona, Medicine Doctoral Studies; Barcelona Spain

4. Center for Advanced Medical Imaging Sciences; Division of Nuclear Medicine and Molecular Imaging; Department of Radiology; Massachusetts General Hospital; Harvard Medical School; Boston MA

5. Harvard NeuroDiscovery Center, Harvard Medical School; Boston MA

6. Department of Psychiatry; University of Pittsburgh School of Medicine; Pittsburgh PA

7. Department of Pharmacology and Chemical Biology; University of Pittsburgh School of Medicine; Pittsburgh PA

8. Department of Neurology; University of Pittsburgh School of Medicine; Pittsburgh PA

9. Geriatric Research Education and Clinical Center, Veterans Administration Pittsburgh Clinical System; Pittsburgh PA

10. C. S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital; Boston MA

Funder

NIH

Harvard NeuroDiscovery Center

NIH National Institute on Aging

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference26 articles.

1. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease;Xia;Alzheimers Dement,2013

2. A highly selective and specific PET tracer for imaging of tau pathologies;Zhang;J Alzheimers Dis,2012

3. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807;Chien;J Alzheimers Dis,2013

4. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration;Cairns;Acta Neuropathol,2007

5. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy);Hauw;Neurology,1994

Cited by 527 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases;Acta Neuropathologica;2024-01-27

2. Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer’s disease based on the A/T(N) research framework;Clinical Neurology and Neurosurgery;2024-01

3. Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-05

4. A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles;Brain Communications;2023-11-16

5. The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases;Nature Communications;2023-10-27